Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults
Psychopharmacology October 6, 2021 Conor H. Murray, Ilaria Tare, Claire Perry et al. 75 citations
Classical psychedelics, including psilocybin and lysergic acid diethylamide (LSD), are under investigation as potential therapeutic agents in psychiatry. Whereas most studies utilize relatively high doses, there are also reports of beneficial effects of “microdosing,” or repeated use of very low doses of these drugs. The behavioral and neural effects of these low doses are not fully understood....